English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
Add to Basket
  Local TagsRelease HistoryDetailsSummary

Released
Journal Article

The clinical effect of galantamine is linked to the nicotinic mode of action

MPS-Authors
/persons/resource/persons147129

Bauer,  Bernd
Radiochemistry, Scientific Services and Development, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society;

/persons/resource/persons147188

Heiss,  Wolf-Dieter
Wolf-Dieter Heiss, Emeriti, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society;

External Resource
No external resources are shared
Fulltext (restricted access)
There are currently no full texts shared for your IP range.
Fulltext (public)
There are no public fulltexts stored in PuRe
Supplementary Material (public)
There is no public supplementary material available
Citation

Mielke, R., Lenz, O., Bauer, B., Herholz, K., Heiss, W.-D., Weichel, C., et al. (2002). The clinical effect of galantamine is linked to the nicotinic mode of action. Neurobiology of Aging, 23(1 Suppl. 1), S82-S82.


Cite as: https://hdl.handle.net/11858/00-001M-0000-0026-D9C8-E
Abstract
There is no abstract available